Drugs / fIPV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03922061 | Mar → Jul 2019 | poliomyelitis | University of Vermont | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fIPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03922061 ↗ |
| Modality | Vaccine | “inactivated polio vaccine (IPV)” NCT03922061 ↗ |
| Route | Other | “fractional-dose inactivated polio vaccine (fIPV) given intradermally” NCT03922061 ↗ |